176 related articles for article (PubMed ID: 26166774)
1. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity.
Barnett GC; Kerns SL; Noble DJ; Dunning AM; West CM; Burnet NG
Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):579-87. PubMed ID: 26166774
[TBL] [Abstract][Full Text] [Related]
2. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing.
Bentzen SM
Radiother Oncol; 1997 May; 43(2):121-31. PubMed ID: 9192956
[TBL] [Abstract][Full Text] [Related]
3. Finding the genetic determinants of adverse reactions to radiotherapy.
Rattay T; Talbot CJ
Clin Oncol (R Coll Radiol); 2014 May; 26(5):301-8. PubMed ID: 24702740
[TBL] [Abstract][Full Text] [Related]
4. Biomarkers of Tumour Radiosensitivity and Predicting Benefit from Radiotherapy.
Forker LJ; Choudhury A; Kiltie AE
Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):561-9. PubMed ID: 26119726
[TBL] [Abstract][Full Text] [Related]
5. [Factors of late radiosensitivity of normal tissues].
Azria D; Pointreau Y; Toledano A; Ozsahin M
Cancer Radiother; 2010 Jul; 14(4-5):250-4. PubMed ID: 20598609
[TBL] [Abstract][Full Text] [Related]
6. Biomarkers of radiation exposure: can they predict normal tissue radiosensitivity?
Chua ML; Rothkamm K
Clin Oncol (R Coll Radiol); 2013 Oct; 25(10):610-6. PubMed ID: 23870757
[TBL] [Abstract][Full Text] [Related]
7. Genetic variation in normal tissue toxicity induced by ionizing radiation.
Popanda O; Marquardt JU; Chang-Claude J; Schmezer P
Mutat Res; 2009 Jul; 667(1-2):58-69. PubMed ID: 19022265
[TBL] [Abstract][Full Text] [Related]
8. Exploiting biological and physical determinants of radiotherapy toxicity to individualize treatment.
Scaife JE; Barnett GC; Noble DJ; Jena R; Thomas SJ; West CM; Burnet NG
Br J Radiol; 2015 Jul; 88(1051):20150172. PubMed ID: 26084351
[TBL] [Abstract][Full Text] [Related]
9. Radiogenomics - current status, challenges and future directions.
Andreassen CN; Schack LM; Laursen LV; Alsner J
Cancer Lett; 2016 Nov; 382(1):127-136. PubMed ID: 26828014
[TBL] [Abstract][Full Text] [Related]
10. Chromosomal in-vitro radiosensitivity of lymphocytes in radiotherapy patients and AT-homozygotes.
Dunst J; Neubauer S; Becker A; Gebhart E
Strahlenther Onkol; 1998 Oct; 174(10):510-6. PubMed ID: 9810318
[TBL] [Abstract][Full Text] [Related]
11. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
Mackay RI; Hendry JH
Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
[TBL] [Abstract][Full Text] [Related]
12. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.
Barnett GC; West CM; Dunning AM; Elliott RM; Coles CE; Pharoah PD; Burnet NG
Nat Rev Cancer; 2009 Feb; 9(2):134-42. PubMed ID: 19148183
[TBL] [Abstract][Full Text] [Related]
13. Prediction of normal tissue radiosensitivity from polymorphisms in candidate genes.
Andreassen CN; Alsner J; Overgaard M; Overgaard J
Radiother Oncol; 2003 Nov; 69(2):127-35. PubMed ID: 14643949
[TBL] [Abstract][Full Text] [Related]
14. Radiogenomics: towards a personalized radiation oncology.
Roberson JD; Burnett OL; Robin N
Curr Opin Pediatr; 2016 Dec; 28(6):713-717. PubMed ID: 27552070
[TBL] [Abstract][Full Text] [Related]
15. [Individual response to ionising radiation: What predictive assay(s) to choose?].
Granzotto A; Joubert A; Viau M; Devic C; Maalouf M; Thomas C; Vogin G; Malek K; Colin C; Balosso J; Foray N
C R Biol; 2011 Feb; 334(2):140-57. PubMed ID: 21333944
[TBL] [Abstract][Full Text] [Related]
16. Genetic variants and normal tissue toxicity after radiotherapy: a systematic review.
Andreassen CN; Alsner J
Radiother Oncol; 2009 Sep; 92(3):299-309. PubMed ID: 19683821
[TBL] [Abstract][Full Text] [Related]
17. Normal tissue radiosensitivity--how important is it?
Burnet NG; Wurm R; Nyman J; Peacock JH
Clin Oncol (R Coll Radiol); 1996; 8(1):25-34. PubMed ID: 8688357
[TBL] [Abstract][Full Text] [Related]
18. Meta-analysis of Genome Wide Association Studies Identifies Genetic Markers of Late Toxicity Following Radiotherapy for Prostate Cancer.
Kerns SL; Dorling L; Fachal L; Bentzen S; Pharoah PD; Barnes DR; Gómez-Caamaño A; Carballo AM; Dearnaley DP; Peleteiro P; Gulliford SL; Hall E; Michailidou K; Carracedo Á; Sia M; Stock R; Stone NN; Sydes MR; Tyrer JP; Ahmed S; Parliament M; Ostrer H; Rosenstein BS; Vega A; Burnet NG; Dunning AM; Barnett GC; West CM;
EBioMedicine; 2016 Aug; 10():150-63. PubMed ID: 27515689
[TBL] [Abstract][Full Text] [Related]
19. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
Barber JB; Burrill W; Spreadborough AR; Levine E; Warren C; Kiltie AE; Roberts SA; Scott D
Radiother Oncol; 2000 May; 55(2):179-86. PubMed ID: 10799730
[TBL] [Abstract][Full Text] [Related]
20. Molecular determinants of radiosensitivity in normal and tumor tissue: A bioinformatic approach.
Pavlopoulou A; Bagos PG; Koutsandrea V; Georgakilas AG
Cancer Lett; 2017 Sep; 403():37-47. PubMed ID: 28619524
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
